Background: Chronic itch is a highly debilitating symptom that underlies many medical disorders with no universally effective treatments. Although unique neuronal signaling cascades in the sensory ganglia and spinal cord have been shown to critically promote the pathogenesis of chronic itch, the role of skinassociated cells remains poorly understood. Objective: We sought to examine the cutaneous mechanisms underlying transient receptor potential vanilloid 4 (TRPV4)-mediated allergic and nonallergic chronic itch. Methods: Expression of TRPV4 in chronic itch and healthy control skin preparations was examined by using real-time RT-PCR. Trpv4 eGFP mice were used to study the expression and function of TRPV4 in the skin by means of immunofluorescence staining, flow cytometry, calcium imaging, and patch-clamp recordings. Genetic and pharmacologic approaches were used to examine the role and underlying mechanisms of TRPV4 in mouse models of dry skin-associated chronic itch and spontaneous scratching associated with squaric acid dibutylester-induced allergic contact dermatitis. Results: TRPV4 is selectively expressed by dermal macrophages and epidermal keratinocytes in mice. Lineage-specific deletion of TRPV4 in macrophages and keratinocytes reduces allergic and nonallergic chronic itch in mice, respectively. Importantly, TRPV4 expression is significantly increased in skin biopsy specimens from patients with chronic idiopathic pruritus in comparison with skin from healthy control subjects. Moreover, TRPV4-dependent chronic itch requires 5-hydroxytryptamine (5-HT) signaling secondary to activation of distinct 5-HT receptors in mice with allergic and those with nonallergic chronic itch conditions. Conclusion: Our study reveals previously unrecognized mechanisms by which TRPV4-expressing epithelial and immune cells in the skin critically and dynamically mediate chronic itch and unravels novel targets for therapeutics in the setting of
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Key words: Transient receptor potential vanilloid 4, chronic itch, macrophage, keratinocyte Chronic itch, a symptom of many primary skin disorders and systemic diseases, is a major medical issue affecting 10% to 20% of the general population and has deleterious effects on both quality of life and productivity. 1, 2 Despite decades of research, how chronic itch is generated at the molecular and cellular levels is poorly understood. Recent studies have identified multiple itch-related G protein-coupled receptors and ion channels in the primary sensory neurons, which enable sensory neurons to detect a variety of pruritogens. [3] [4] [5] However, upstream pathways, such as the identity of putative receptors that trigger epithelial and immune cells to elicit itch, remain unknown. Lack of this critical information has severely limited the development of effective therapies for most types of chronic itch.
Transient receptor potential vanilloid 4 (TRPV4) is a Ca 21 -permeable cation channel in the TRPV family and is abundantly expressed in the skin, renal, and urinary bladder epithelia (www.biogps.org). 6, 7 TRPV4 is a polymodal sensory transducer that integrates a variety of thermal, mechanical, and chemical stimuli, including warmth (278C to 358C), hypo-osmotic stimulation, and many inflammatory metabolites. 8 As a result, TRPV4 channels are involved in many physiologic and pathologic processes. Although it was recently reported that TRPV4 is involved in acute itch elicited by exogenously applied histamine and 5-hydroxytryptamine (5-HT), its precise mechanism in itch induction remains controversial. Indeed, whether TRPV4 predominantly mediates itch indirectly through skinassociated cells or by directly stimulating dorsal root ganglion (DRG) neurons is an active area of investigation. 9, 10 More importantly, the role of TRPV4 in the development of chronic itch remains unexplored.
In the current study we show that these osmosensitive TRPV4 channels are selectively expressed by skin keratinocytes and dermal macrophages and that their activation promotes downstream 5-HT signaling, resulting in itch-specific behavioral responses in mouse models of chronic itch. Importantly, TRPV4-expressing macrophages and keratinocytes are differentially involved in the generation of spontaneous itch behaviors in mouse models of allergic and nonallergic chronic itch, respectively. Furthermore, we identified increased expression of TRPV4 in the skin of patients with chronic idiopathic pruritus (CIP). Collectively, our data demonstrate that TRPV4-expressing cells in the skin are a critical component in the pathogenesis of chronic itch. Experiments were performed 7 days after the last day of tamoxifen administration. Animals were acclimatized to the experimental room in advance of experiments. All behavioral tests were videotaped from a side angle, and behavioral assessments were done by observers blind to the treatments or genotypes of animals. All experimental procedures were approved by the Institutional Animal Care and Use Committee of University of Texas Health Science Center at Houston and the Institutional Animal Care and Use Committee at Washington University School of Medicine and were in accordance with guidelines provided by the National Institutes of Health and the International Association for the Study of Pain. All mice were randomly allocated to different experimental groups by laboratory managers, who were blinded to the experimental design. All mice were included in the analysis unless they died.
METHODS Animals

Human PBMCs and skin biopsy specimens
Human peripheral blood samples were obtained from patients undergoing routine skin cancer surgery in an outpatient dermatology clinic, as approved by the Washington University in St Louis Institutional Review Board (IRB; Protocol 201507042). Deidentified human control skin was obtained from noncancerous marginal skin from patients (average age of control subjects, 74.5 6 4.2 years) undergoing routine skin cancer surgery under an IRB-exempt protocol. Skin from patients with CIP was obtained directly from patients with a firm diagnosis of CIP (average age of patients with CIP, 74.3 6 2.2 years), as approved by the Washington University in St Louis IRB (Protocol 201412117). The numeric rating scale itch score for CIP was examined on a scale of 0 to 10 as a peak value during the week before the examination. A thorough work-up was performed to establish the diagnosis of CIP by means of exclusion of other cutaneous and systemic causes of pruritus, including psychiatric and neurologic conditions, dialysis-dependent renal failure, biliary dysfunction, thyroid abnormalities, HIV/AIDS, hepatitis B, and hepatitis C. None of the patients had a history of malignancy. Informed consent was obtained from each subject before all procedures.
Single-cell suspensions from mouse and human skin tissues Fresh mouse ear skin preparations and human skin biopsy specimens were cut and separated with forceps and digested in 0.25 mg/mL Liberase TL (Roche, Mannheim, Germany) in Dulbecco modified Eagle medium for 90 minutes at 378C. Samples were mashed through 70-mm cell strainers and washed with Dulbecco modified Eagle medium supplemented with 5% FBS, 1% L-glutamine (GIBCO, Carlsbad, Calif), and 1% penicillin/streptomycin (GIBCO). Single-cell suspensions were used for subsequent calcium imaging, staining for flow cytometry, and cell sorting for RT-PCR.
Mouse and human epidermal keratinocyte culture
The skin keratinocyte culture was prepared according to a previous study. 12 In brief, the skin of newborn mouse pups (P0-P2) or human skin biopsy specimens were removed and placed in a Petri dish containing 2.5% Dispase II (Life Technologies, Grand Island, NY) and incubated at 48C overnight. The epidermis was then separated from subcutaneous tissues. Keratinocytes were dissected by means of gentle scraping and flushing with culture medium. Harvested cells were plated on coverslips coated with collagen IVand cultured in the serum-free, fully supplemented keratinocyte medium CnT-07 (for mouse keratinocytes; CELLnTEC Advanced Cell Systems, Bern, Switzerland) or keratinocyte-SFM medium supplemented with bovine pituitary extract and epidermal growth factor (for human keratinocytes; Invitrogen, Carlsbad, Calif) under a humidified atmosphere of 5% CO 2 /95% air at 378C for 2 days before use.
Isolation and short-term culture of mouse DRG neurons
Mouse spinal columns were removed and placed in ice-cold HBSS; neurons were acutely dissociated and maintained, as previously described. 13 In brief, laminectomies were performed, and bilateral DRGs were dissected out. After removal of connective tissues, DRGs were transferred to 1 mL of Ca 21 
Extraction and isolation of mouse platelets
Whole blood was collected in a tube containing 3.8% Na citrate at a ratio of 9:1 after anesthesia was obtained. Anticoagulant whole blood was centrifuged at 100g for 10 minutes without brake. Platelet-rich plasma was transferred to a new tube, and 1 mmol/L prostaglandin E 1 was added and incubated for 5 minutes. Another volume of Na citrate was added, and centrifugation was done at 400g for 10 minutes. Plasma was discarded, and platelets were resuspended in HBSS containing 4 mmol/L Fura2-AM (Life Technologies). Platelets were plated on coverslips coated with poly-L-lysine and incubated at room temperature for 1 hour. The platelets were used after washing with fresh HBSS for at least 30 minutes by using a calcium imaging assay.
Preparation of skin superfusate
Skin biopsy specimens were dissected from the backs of mice, chopped into small pieces, and incubated in HBSS at 378C for 30 minutes. The superfusate was collected by means of centrifugation before we carried out the calcium imaging experiment.
Ca 21 imaging
Fura-2-based ratiometric measurement of intracellular Ca 21 ([Ca 21 ] i ) was performed, as described previously. 13 Freshly isolated skin-resident cells, cultured epidermal keratinocytes, cultured DRG neurons, and isolated PBMCs and platelets were loaded with 4 mmol/L Fura-2 AM (Life Technologies) in culture medium at 378C for 60 minutes. Cells were then washed 3 times and incubated in HBSS at room temperature for 30 minutes before use. Fluorescence values at excitation wavelengths of 340 and 380 nm were recorded on an inverted Nikon Ti-E microscope equipped with 340-, 360-, and 380-nm excitation filter wheels by using NIS-Elements imaging software (Nikon Instruments, Melville, NY). Fura-2 ratios (F340/F380) were used to reflect changes in [Ca 21 ] i values on stimulation. Values were obtained from 100 to 250 cells in time-lapse images from each coverslip. The threshold of activation was defined as 3 SDs above the average (approximately 20% greater than the baseline).
Whole-cell patch-clamp recording
Whole-cell patch-clamp recordings were performed with an EPC 10 amplifier (HEKA Elektronik, Lambrecht/Pfalz, Germany) or multiclamp 700B amplifier (Molecular Devices, Sunnyvale, Calif) at room temperature (228C to 248C) on the stage of an inverted phase-contrast microscope equipped with a filter set for green fluorescent protein (GFP) visualization. Pipettes with sucrose). The whole-cell membrane currents were recorded by using voltage ramping from 2100 to 1100 mV for 500 ms at a holding potential of 0 mV. Data were acquired with PatchMaster (HEKA Elektronik, Lambrecht/Pfalz, Germany) or Clampex 10 (Molecular Devices, Sunnyvale, Calif). Currents were filtered at 2 kHz and digitized at 10 kHz. Data were analyzed and plotted with Clampfit 10 (Molecular Devices). Values are presented as means 6 SEMs (n represents the number of measurements).
Immunofluorescence
Adult mice, aged 6 to 16 weeks, were asphyxiated with CO 2 and perfused transcardially with 200 mL of PBS (pH 7.3), followed by 200 mL of fixative (4% paraformaldehyde in 0.1 mol/L phosphate buffer, pH 7.3, or Zamboni fixative [2% paraformaldehyde, 15% vol/vol saturated picric acid, and 0.1 mol/L phosphate buffer, pH 7.3]). Tissues were removed and postfixed overnight at 48C in the same fixative. All tissues were cryoprotected overnight in 30% sucrose in 0.1 mol/L phosphate buffer, pH 7.3, frozen in optimal cutting temperature medium (OCT), sectioned with a cryostat at 20 mm, mounted on a Superfrost Plus slide (Fisher Scientific, Pittsburgh, Pa), and stored at 2208C. Frozen slides were dried at room temperature for 1 hour and washed 3 times in PBS with 0.1% Triton X-100 (PBS1TX), blocked for 30 minutes to 1 hour in PBS1TX containing 10% donkey serum, and incubated overnight at 48C with primary antibodies diluted in blocking solution (see Table E1 in this article's Online Repository at www.jacionline.org). Sections were then washed 3 times in PBS1TX, incubated for 2 hours at room temperature with secondary antibodies conjugated to Alexa Fluor 488 fluorochrome (Invitrogen) or Cy3 fluorochromes (Jackson ImmunoResearch, West Grove, Pa), and diluted 1:500 in blocking solution. Sections were then washed 3 times in PBS1TX and mounted in anti-fade medium (Vectashield; Vector Laboratories, Burlingame, Calif). All preparations were examined with a Nikon A1 Confocal Laser Microscope System. Images were taken and analyzed in NIS-Elements.
Flow cytometry
Isolated ear skin cells from Trpv4 eGFP mice were stained with anti-mouse fluorescently conjugated antibodies: CD11b (eBioscience, San Diego, Calif), CD11c (BioLegend, San Diego, Calif), CD3e (eBioscience), B220 (BD PharMingen, San Jose, Calif), and CCR2 (R&D Systems, Minneapolis, Minn). Samples were acquired on a BD LSR Fortessa flow cytometer (BD Biosciences) and analyzed with FlowJo software (version 10; TreeStar, Ashland, Ore; see Table E1 ).
Cell sorting and RT-PCR
Isolated GFP
1 and GFP 2 skin cells were sorted with a FACSAria II (BD Biosciences). Total RNA was extracted with TRIzol reagent (Invitrogen), according to the manufacturer's instructions. RNA was treated with DNase I (Invitrogen), and cDNA was synthesized in vitro by using the ThermoScript RT-PCR System kit (Invitrogen). PCR conditions were as follows 958C for 3 minutes and 40 cycles of 30 seconds at 958C, 30 seconds at 528C, and 60 seconds at 728C. Sequences of the primers used were as follows: GFP forward, 59-AAGGGCATCGACTTCAAGG-39; GFP reverse, 59-TGCTTGT CGGCCATGATATAG-39; mTRPV4 forward, 59-CCTGCTGGTCACCTAC ATCA-39; mTRPV4 reverse, 59-CTCAGGAACACAGGGAAGGA-39; murine glyceraldehyde-3-phosphate dehydrogenase (mGAPDH) forward, 59-GCACAGTCAAG GCCGAGAAT-39; and mGAPDH reverse, 59-GCCT TCTCCATGGTGGTGAA-39.
Quantitative RT-PCR
Total RNA was extracted from human skin tissue by using the RNeasy kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions. RNA was treated with DNase I (Invitrogen), and cDNA was synthesized in vitro by using the ThermoScript RT-PCR System kit (Invitrogen). Primer sequences are as follows: hTRPV4 forward, 59-AGAACTTGGGCATCATCA ACGAG-39; hTRPV4, reverse 59-GTTCGAGTTCTTGTTCAGTTCCAC-39; hTRPV3 forward, 59-GCTGAAGAAGCGCATCTTTGCA-39; hTRPV3 reverse, 59-GTCAGCTTGTGCATGAGGAAG-39; hGAPDH forward, 59-GT CGGAGTCAACGGATTT G-39; and hGAPDH reverse, 59-TGGGTGGAAT CATATTGGAA-39. Reactions were carried out in a volume of 20 mL per reaction containing 10 mL of SYBR Green master mix (23; Applied Biosystems, Foster City, Calif), 0.5 mL of cDNA, 5 mL of 0.4 mmol/L primer mix, and 4.5 mL of water by using the StepOnePlus real-time PCR system (Applied Biosystems). The generated cycle threshold (C t ) value of human TRPV4 was normalized to its respected C t value of GAPDH (DC t ). The value of DC t for the CIP group was further normalized to that for the control group to yield DDC t . Data were expressed as 2 2DDCt .
Conditional platelet depletion
Platelet depletion was accomplished by using intraperitoneal injections of diphtheria toxin (DTX; 400 ng per mouse) every 48 hours for a total of 3 treatments to Pf4-Cre 1 ;iDTR mice 14 and confirmed by counting the number of platelets in blood obtained from the facial vein. Only animals with platelet counts reduced to less than 15% of the value before DTX administration were used for further experiments.
Mouse model of chronic dry skin itch
In the dry skin model 15 the rostral backs of mice were treated twice daily with cutaneous application of acetone/ether (1:1) mixture followed by water (AEW). After a 7-day treatment, mice showed robust spontaneous scratching, and the treated skin area exhibited decreased stratum corneum hydration and increased transepidermal water loss, which mimic the symptoms of dry skin in patients. Hind-paw scratching directed toward the treated area was quantified by recording the number of incidences of scratching bouts for 60 minutes daily. After the recording, the videotapes were played back, and all behavioral assessments were done by observers blind to the treatments or genotypes of the animals.
Mouse model of allergic contact dermatitis
The contact sensitizer squaric acid dibutylester (SADBE; Tokyo Chemical, Tokyo, Japan) was used to elicit contact hypersensitivity in the mouse as a model of allergic contact dermatitis (ACD) in human subjects. 16 Mice were sensitized by means of topical application of 20 mL of 0.5% SADBE in acetone to shaved abdominal skin once a day for 3 consecutive days. Five days later, the SADBE-treated group was challenged with a topical application of 20 mL of 0.5% SADBE to the hairy skin on the nape of the neck once a day for 3 consecutive days, whereas acetone alone was used as the vehicle control. Scratching behavior with the hind paw was quantified by recording the number of incidences of scratching bouts for 60 minutes daily.
Statistical analysis
Values are reported as means 6 SEMs. The unpaired or paired t test was used for comparison between 2 groups or 1-way ANOVA, and repeated measures tests followed by Tukey-Kramer or Bonferroni post hoc analysis were used for comparison among multiple groups occurring over time. All tests were carried out as 2-tailed tests. P values of less than .05 were considered statistically significant. All experiments were repeated at least twice, unless otherwise noted. RESULTS TRPV4 is required for generating spontaneous scratching in mouse models of both allergic and nonallergic chronic itch TRPV4 has been implicated in both inflammatory pain and acute itch responses elicited by intradermal injections of J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 2 histamine or 5-HT. 9, 10, 17 Although acute itch can serve protective roles against potential threats and dangers in the environment (eg, disease-borne insects), chronic itch is universally pathologic and highly debilitating. 5 To investigate whether TRPV4 is involved in chronic itch, we examined the mRNA expression of TRPV4 in pruritic skin from patients with CIP. 18 Classically, patients with CIP present with chronic pruritus secondary to skin barrier dysfunction in the absence of a clinically defined primary dermatologic disorder. 18 Indeed, TRPV4 mRNA expression was significantly increased in skin biopsy specimens from patients with CIP in comparison with healthy control skin (Fig 1, A) . On the other hand, expression of TRPV3, another channel implicated in itch, was not significantly increased in the patients with CIP. 19, 20 These results suggest that TRPV4 might be involved in the pathogenesis of chronic itch in human subjects.
Next, we examined the role of TRPV4 in a mouse model of dry skin-associated chronic itch induced by AEW treatment, 3, 21, 22 which produces robust scratching and extensive epidermal hyperplasia in wild-type (WT) mice. 15 We found that the number of spontaneous scratches was markedly reduced in the Trpv4 2/2 mice at each of the measured time points from day 3 to day 7 after AEW treatment (Fig 1, B , and data not shown). This was additionally confirmed by pharmacologic inhibition of TRPV4 by HC067, 23 which substantially attenuated spontaneous scratching in the AEW model when applied either systemically or topically (Fig 1, C) . AEW-elicited scratching critically depends on the application of distilled water, 2 which is reminiscent of a condition called aquagenic pruritus, in which water exposure induces intense itching, especially in elderly patients. 24, 25 Furthermore, exposure to water is known to exacerbate dry skin and itching in patients with conditions such as chronic hand dermatitis. 26 Because distilled water is extremely hypotonic (approximately 17 mOsm), 27 we hypothesized that osmotic stress driven by distilled water promotes the scratching response. Indeed, mice treated with distilled water with increased osmolarity at 0.45% saline (141.5 mOsm) displayed significantly reduced scratching, which was further reduced at a concentration of 0.9% saline (283 mOsm) after the acetone and ether challenge (Fig 1, D) . Consistent with both in vitro and in vivo studies showing that TRPV4 is a molecular sensor for extracellular osmolarity in mammals, 11, 28, 29 these results suggest that TRPV4 is an osmoreceptor in the skin of mice and functionally required to generate dry skin-associated itch, which recapitulates the symptoms of dry skin in human subjects. 15 Furthermore, we investigated whether TRPV4 is involved in spontaneous scratching associated with ACD by using the contact sensitizer SADBE. 16 WT mice receiving SADBE treatment displayed a robust scratching response when compared with mice treated with vehicle control only (data not shown). The Trpv4 2/2 mice displayed a markedly reduced scratching response after SADBE treatment when compared with WT mice (Fig 1, E) . Similarly, systemic or topical administration of HC067 significantly reduced spontaneous scratching bouts in WT mice treated with SADBE (Fig 1, F) . Combined, these results suggest that TRPV4 contributes to both allergic and nonallergic chronic itch in mice.
Both mouse and human keratinocytes and myeloid cells express functional TRPV4 channels
Although TRPV4 is known to be expressed by both neurons and nonneuronal cells, the precise expression pattern of TRPV4 across tissues is controversial.
30,31 Therefore we took a transgenic approach by using BAC transgenic Trpv4 eGFP mice 32 and determined the expression of TRPV4-enhanced green fluorescent protein (eGFP) in the skin. We found that both K14-expressing keratinocytes 33 in the epidermis and F4/80-expressing macrophages in the dermis were TRPV4-eGFP 1 (Fig 2, A) . RT-PCR analysis with total mRNA isolated from sort-purified eGFP 1 and eGFP 2 cells from mouse skin single-cell suspensions confirmed a correlation between the expression of TRPV4 and eGFP transcripts, further validating the specificity of the BAC transgenic mice (Fig 2, B) . Flow cytometry with skin cell suspensions further showed that a subset of TRPV4-eGFP 1 cells expressed CD11b and CCR2, as well as low levels of CD11c, which is reminiscent of CCR2/CD11b-positive dermal macrophages (Fig 2, C , and see Fig E1 in this article's Online Repository at www.jacionline.org). 34 In addition, TRPV4-eGFP 1 cells were also immunopositive for CD68, CD206, and
TRPV4 expression is increased in skin biopsy specimens of patients with CIP, and TRPV4 function is required for generating mouse models of both allergic and nonallergic chronic itch. A, Bar charts show averaged itch numeric rating scale scores and expression of mRNA transcripts for TRPV4 and TRPV3 in patients with CIP and healthy control subjects. *P <.05 and **P < .01, Student t test (n 5 8). n.s., Not significant versus control group. B, Spontaneous scratches in Trpv4 1/1 and Trpv4 2/2 mice after 7 days of AEW treatment. ***P < .001, Student t test (n 5 7). C, Spontaneous scratches in Trpv4 1/1 mice after 7 days of AEW treatment were reduced by HC067 (20 mg/kg, either intraperitoneal [i.p.] or topical application) compared with vehicle. *P <.05, Student t test (n 5 8-9). D, Spontaneous scratches after treatment with the 1:1 mixture of acetone and ether, followed by 0.9% NaCl, 0.45% NaCl, or distilled water, respectively. **P < .01, ANOVA (n 5 5-7). E, Spontaneous scratches in Trpv4 1/1 and Trpv4 2/2 mice after SADBE treatment. *P < .05, Student t test (n 5 6). CD163, all of which are cell markers commonly used for tissue macrophages (see Fig E2, A, in this article's Online Repository at www.jacionline.org). 35 We next assessed the function of TRPV4 in freshly isolated skin-resident cells using live cell Ca 21 imaging and patch-clamp recordings. Application of GSK101, a potent and selective TRPV4 agonist, 36 induced a robust [Ca 21 ] i response in a subset of cells in WT but not Trpv4 2/2 skin single-cell suspensions, which are enriched with resident immune cells (Fig 2, D) . 37 Moreover, GSK101 also activated large whole-cell membrane currents with a characteristic current-voltage relationship for TRPV4 and [Ca 21 ] i responses in freshly isolated TRPV4-eGFP 1 cells, which was severely attenuated by either GSK219 or HC067, 2 selective TRPV4 antagonists (Fig 2, E , and see Fig  E2, B and C) . 23, 38 Consistent with previous studies showing the presence of functional TRPV4 in mouse keratinocytes, 33 we found that GSK101 evoked a large [Ca 21 ] i response in WT but not TRPV4-deficient mouse primary keratinocytes (see Fig E3 in this article's Online Repository at www.jacionline.org). Similarly, we also demonstrated that GSK101 elicited robust [Ca 21 ] i responses in human primary epidermal keratinocytes, freshly isolated human forearm skin single-cell suspensions, and human PBMCs, all of which were abolished by GSK219, suggesting that, as in mice, human skin-resident cells and mononuclear cells also possess functional TRPV4 channels (see Fig E4 in this article' s Online Repository at www.jacionline. org). Combined, these results demonstrate that activation of TRPV4 can lead to functional responses in both keratinocytes and dermal myeloid cells in both mice and human subjects.
F, SADBE-induced spontaneous scratches in
TRPV4-expressing macrophages and keratinocytes are differentially involved in allergic and nonallergic chronic itch
Consistent with TRPV4-expressing skin-resident cells being critical to the genesis of chronic itch in mice, we showed that Bar charts at right show summarized data. ***P < .001, ANOVA (n 5 5).
J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 2 AEW or SADBE treatment produced epidermal hyperplasia, with a marked increase in the number of TRPV4-eGFP 1 keratinocytes, as well as dermal TRPV4-eGFP 1 cells, moving toward the epidermal-dermal border (Fig 3, A-C) . In addition, TRPV4 mRNA transcripts were also increased in the skin of mice treated with either AEW or SADBE (Fig 3, D) . Collectively, these studies demonstrate that TRPV4 expression is not only functional but also enriched in the skin under chronic itch conditions. To further determine the types of TRPV4-expressing cells contributing to chronic itch, we generated TRPV4 flox mice and crossed them to inducible keratinocyte-specific K14
CreERT and macrophage-specific Cx3cr1
CreERT mice. After tamoxifen treatment, the AEW-induced spontaneous scratching response was significantly reduced in the K14-Cre 1 mice compared with their K14-Cre -littermates (Fig 3, E) . However, the AEW-induced spontaneous scratching response was not significantly affected in Cx3cr1-Cre 1 mice (Fig 3, F) . On the other hand, SADBE-induced spontaneous scratching was significantly attenuated in Cx3cr1-Cre 1 but not in K14-Cre 1 mice compared with their respective Cre 2 littermates (Fig 3, G  and H) . These studies suggest that TRPV4 function in macrophages and keratinocytes contributes differentially to the pathogenesis of allergic and nonallergic chronic itch in mice.
5-HT signaling is involved critically in TRPV4-dependent chronic itch
To identify the skin-derived chemical mediator or mediators of TRPV4-mediated scratching response, we prepared AEW-treated skin superfusates from both 21 ] i response in a subset of DRG neurons. By contrast, the Trpv4 2/2 AEW skin superfusate activated significantly fewer sensory neurons, suggesting that TRPV4 mediates the release of neuromediators in the AEW-treated skin (Fig 4, A) . Interestingly, Trpv4 1/1 AEW skin superfusate activated approximately 30% of all 5-HT-responsive DRG neurons, whereas less than 5% of these neurons were activated by Trpv4 2/2 AEW skin superfusate (Fig 4, B) . Therefore TRPV4 deficiency leads to significantly fewer 5-HT-sensitive sensory neurons responsive to AEW skin superfusates, suggesting that TRPV4 deficiency might result in significantly reduced 5-HT release in the skin in response to AEW treatment.
Biosynthesis of 5-HT (Fig 4, C) is catalyzed by the rate-limiting enzyme tryptophan hydroxylase (TPH), and inhibition of TPH activity by a TPH inhibitor p-chlorophenylalanine (pCPA) has been commonly used to investigate the effects of 5-HT depletion on animal behaviors. 39 Thus we examined whether chemical depletion of 5-HT affected AEW-induced dry (Fig 4, D) and SADBE-treated (Fig 4, E) mice with pCPA or pCPA plus 5-hydroxytryptophan (5-HTP). *P < .05 and ***P < .001, ANOVA (n 5 8-10). n.s., Not significant. F, Spontaneous scratching in Htr2a 1/1 and Htr2a 2/2 mice after SADBE treatment. *P < .05, Student t test (n 5 5). G, Spontaneous scratching in mice treated with vehicle, ketanserin, or Htr7 antagonist SB269970 (SB269) after SADBE treatment. *P < .05, ANOVA (n 5 6). n.s., Not significant. H, Spontaneous scratching in Htr7 1/1 and Htr7 2/2 mice after SADBE treatment. Student t test (n 5 6). n.s., Not significant.
I, Spontaneous scratching in Htr2a 1/1 and Htr2a 2/2 mice after AEW treatment. Student t test (n 5 9). n.s., Not significant. J, Spontaneous scratching after AEW treatment in mice treated with vehicle, Htr7 antagonist SB269970 (SB269), or ketanserin. **P < .01, ANOVA (n 5 6-7). n.s., Not significant. K, Spontaneous scratching after AEW treatment in Htr7 1/1 and Htr7 2/2 mice. ***P < .001, Student t test (n 5 10-11).
skin-associated chronic itch and SADBE-induced chronic allergic itch. The results revealed that administration of pCPA markedly inhibited spontaneous scratching in mice treated with either AEW or SADBE (Fig 4, D and E) . To validate that deficiency in 5-HT but not other monoamines mediated the pCPA effect, we concomitantly administered pCPA and 5-hydroxytryptophan, which is converted to 5-HT without the involvement of TPH. Indeed, administration of 5-hydroxytryptophan rescued spontaneous scratching in mice treated with pCPA in both AEW-and SADBE-induced chronic itch models (Fig 4, D and E) . Consistent with the finding that 5-HT is a downstream neuromediator of TRPV4-elicited scratching, administration of ketanserin, a selective antagonist of Htr2a shown to mediate 5-HT-elicited scratching in mice, 40 or genetic ablation of Htr2a function but not inhibition of Htr7 function significantly reduced spontaneous scratching in mice treated with SADBE (Fig 4, F-H) . To our surprise, the number of spontaneous scratches in the AEW-induced chronic dry skin-associated itch was not substantially changed in the Htr2a 2/2 or WT mice treated with ketanserin (Fig 4, I and J) . In contrast, the number of spontaneous scratches in the AEW model was substantially reduced by either pharmacologic inhibition or genetic ablation of the function of Htr7, which was also shown to mediate 5-HT-induced itch in mice (Fig 4, J and K) , 41 suggesting that Htr7 but not Htr2a signaling likely plays a major role in chronic dry skin-associated itch. Together, these results suggest that both Htr2a and Htr7 are critically involved in TRPV4-dependent chronic itch.
Platelets are required to generate TRPV4-mediated chronic itch
It is well known that mast cell degranulation increases tissue histamine concentrations, leading to activation of TRPV1 1 pruriceptive sensory neurons and generation of histaminedependent itch. 4 In addition to histamine, mast cells also represent a major source of 5-HT. 42 Therefore we examined whether TRPV4-eGFP was expressed by mast cells by using streptavidin rhodamine. 43 However, there was no colocalization of TRPV4-eGFP with streptavidin rhodamine, suggesting that mast cells are not likely to express TRPV4 (Fig 5, A) . In agreement with this finding, spontaneous scratching responses in mice treated with AEW or SADBE were not significantly altered in the mast cell-deficient Kit W-sh/W-sh ''sash'' mice when compared with WT control mice (Fig 5, B and C) , suggesting that mast cell-derived 5-HT is not a major contributor to TRPV4-dependent chronic itch.
In addition to mast cells, platelets are the other major source for 5-HT in the skin. 44 Although it is understood increasingly that platelets have roles in inflammatory and immune processes in addition to their function in hemostasis and thrombosis, the role of platelets in the pathogenesis of chronic itch has not been studied. To investigate whether platelets are required for TRPV4-mediated itch, we used a conditional platelet depletion model by crossing the Pf4
Cre transgenic line with the Cre-dependent Rosa26 DTR line (iDTR), followed by DTX injections.
14 Platelet numbers in peripheral blood of the Pf4-Cre 1 mice were markedly reduced after DTX injections compared with those in DTX-treated Pf4-Cre 2 littermates, but no other blood cells were affected (Fig 5, D, and data not shown). littermates, as measured by using the rotarod test (see Fig E5) , confirming that DTX treatment does not affect acute thermal and mechanical pain sensations. We next tested the responses of Pf4-Cre 1 mice and their Pf4-Cre 2 littermates subjected to treatment with AEW or SADBE and showed that DTX-treated Pf4-Cre 1 mice had substantially attenuated spontaneous itch behaviors induced by AEW or SADBE treatment compared with DTX-treated Pf4-Cre 2 littermates (Fig 5, E and F) . Together, these results strongly suggest that platelets, but not mast cells, are required for TRPV4-mediated chronic itch responses.
Multiple pathways are involved in platelet activation, including those activated by adenosine diphosphate through the P2Y12 receptor and fibrinogen through the platelet glycoprotein IIb/IIIa receptors. 45 Thus we investigated whether selective inhibition of the P2Y12 or glycoprotein IIb/IIIa receptors affects (Fig 5, B) or SADBE (Fig 5, C) treatment was not significantly affected in the sash mice. Student t test (n 5 6-7). n.s., Not significant versus the WT control group. D, Platelet count in Pf4-Cre 2 and Pf4-Cre 1 mice 6 days after DTX treatment. **P < .01, Student t test (n 5 7-8). E and F, Spontaneous scratching responses induced by AEW (Fig 5, E) or SADBE (Fig 5, F) in Pf4-Cre 2 mice (n 5 5 for AEW and SADBE) and Pf4-Cre 1 mice (n 5 6 for AEW and SADBE). *P < .05, Student t test. G and H, Spontaneous scratching responses induced by AEW (Fig 5, G) or SADBE (Fig 5, H) in the absence or presence of eptifibatide or clopidogrel. *P < .05, ANOVA (n 5 6).
TRPV4-mediated chronic itch responses by using the selective P2Y12 receptor antagonist clopidogrel or a selective inhibitor of the glycoprotein IIb/IIIa receptors, eptifibatide, both of which are antiplatelet drugs approved by the US Food and Drug Administration. Indeed, concomitant application of clopidogrel or eptifibatide severely attenuated AEW-and SADBE-induced spontaneous scratching (Fig 5, G and H) . Combined, these results strongly suggest that platelet activation is critical to TRPV4-mediated chronic itch responses and that cutaneous platelets are likely the sources of 5-HT release in response to AEW or SADBE treatment. Finally, we asked whether TRPV4 is functionally expressed by platelets isolated from the peripheral blood of Trpv4 eGFP mice. We did not detect TRPV4-eGFP in platelets. Furthermore, live-cell Ca 21 imaging also did not detect [Ca 21 ] i response elicited by addition of GSK101, although it induced a robust [Ca 21 ] i response in TRPV4-eGFP 1 blood-derived leukocytes (see Fig E6 in this article' s Online Repository at www. jacionline.org). These results suggest that TRPV4 does not directly mediate platelet activation but rather does so through the release of unknown proinflammatory mediators after activation of the TRPV4-expressing skin-resident cells, which induces activation of platelets to release 5-HT and produce chronic itching.
DISCUSSION
Our findings that TRPV4 function is required for producing spontaneous scratching in dry skin-associated chronic itch and SADBE-induced spontaneous scratching 15, 16 provide strong evidence for a major role of the TRPV4-expressing skin-resident cells in the pathogenesis of multiple types of chronic itch. We also revealed TRPV4 function in human skin cells and increased TRPV4 expression in skin biopsy specimens of patients with CIP. Furthermore, we demonstrated that 5-HT is a critical downstream mediator of TRPV4-mediated spontaneous scratching and that distinct 5-HT receptors are required for producing TRPV4-mediated allergic and nonallergic chronic itch. Our results support a model in which TRPV4 1 skin-resident cells are key signaling components in the pathogenesis of chronic itch.
Our data show that TRPV4 expression is upregulated by treatment of AEW or SADBE on the skin, as reflected by an increase in the numbers of TRPV4-eGFP 1 myeloid cells and keratinocytes, as well as increased TRPV4 mRNA transcripts. Moreover, loss of TRPV4 function severely attenuates spontaneous scratching in both AEW-and SADBE-induced chronic itch models, highlighting the importance of TRPV4 in the pathogenesis of chronic itch and suggesting that cutaneous TRPV4 signaling is critically involved in the pathogenesis of chronic itch in mice. Furthermore, our findings that the osmosensitive TRPV4 expressed by skin-resident cells mediates the scratching response elicited by osmotic stress in the AEW-induced chronic itch model might provide the molecular and cellular basis of aquagenic pruritus of the elderly. We also found a significant increase in TRPV4 expression in patients with CIP, further supporting a general role of TRPV4 in mediating chronic itch in both rodents and human subjects.
Interestingly, using conditional knockdown of TRPV4 expression from keratinocytes and dermal macrophages, we found that TRPV4-expressing keratinocytes are critically involved in AEW-induced dry skin-associated chronic itch but not spontaneous scratching in mice with SADBE-induced ACD. Conversely, TRPV4-expressing dermal macrophages are required for generating chronic itch in the SADBE-induced ACD model but not AEW-induced dry skin-associated chronic itch. These results are consistent with our findings that osmotic stress mediates AEW-induced spontaneous scratching. Because TRPV4-expressing epidermal keratinocytes are the first skin cells to access water after barrier disruption, which is an important step in generation of the AEW-induced dry skin model, 15 we speculate that activation of TRPV4-mediated signaling in epidermal keratinocytes by water is largely responsible for AEW-induced chronic itching.
Although the mechanism of SADBE in patients with ACD is not fully understood, activation of T cell-mediated immunity is critically involved in the generation of ACD. 46 In addition to T cells, it was also reported that there is increased migration of dermal innate immune cells, which are important to the sensitization in ACD. 47, 48 Indeed, we detected a marked increase in the number of TRPV4-expressing dermal macrophages after treatment of SADBE. Our results suggest that dermal macrophages might not only regulate skin inflammation but also chronic itch in patients with SADBE-induced ACD.
Consistent with previous studies showing that 5-HT-but not histamine-elicited responses are sensitized by AEW treatment, 49 we found that chemical depletion of 5-HT by pCPA severely attenuated spontaneous scratching in mice treated with AEW or SADBE. Although dermal mast cells are rich in 5-HT, our results do not support the involvement of mast cells in TRPV4-mediated scratching responses for the following observations: (1) mast cells do not express TRPV4-eGFP, and (2) consistent with previous studies, 15 we found that the spontaneous scratching responses induced by AEW or SADBE was not altered by mast cell deficiency. Instead, we showed that DTX-induced depletion of platelets in Pf4-Cre 1 mice severely attenuated spontaneous scratching in mice treated with AEW or SADBE, suggesting that platelet-derived 5-HT is required for TRPV4-mediated chronic itch. In addition, platelets are critical to leukocyte recruitment in chronic skin inflammation through formation of platelet-leukocyte aggregates through P-selectin in peripheral blood and secretion of chemokines at inflamed sites. 50 Furthermore, platelets can also migrate extravascularly and accumulate in inflammatory lesions concomitantly with leukocytes and have been associated with many inflammatory disorders, including asthma, arthritis, and inflammatory bowel disease. 51 Our results showed that Htr2a, one of many 5-HT-responsive G protein-coupled receptors, is involved in SADBE-induced spontaneous scratching based on our pharmacologic inhibition and genetic ablation studies. However, the Htr7 rather than the Htr2a receptor mediates AEW-induced chronic dry skin-associated itch. Although the exact mechanisms underlying the involvement of multiple subtypes of 5-HT receptors in different mouse models of chronic itch remain to be elucidated, our results show that both AEW-and SADBE-induced chronic itch require 5-HT signaling initiated by activation of TRPV4-expressing epithelial and immune cells in the skin, highlighting heterogeneous modules of chronic itch development through distinct TRPV4/5-HT receptor signaling axes. Recognizing the versatility and selectivity of 5-HT receptor signaling in patients with chronic itch might be critical to the development of effective therapies against different forms of chronic itch with distinct causes.
In summary, we have shown that the TRPV4-mediated allergic and nonallergic chronic itch involves activation of a series of cellular networks involving TRPV4-expressing keratinocytes, dermal macrophages, platelets, and pruriceptors through paracrine signaling in the skin. Because chronic itch originates in the skin, identification of TRPV4-dependent, itch-specific cellular signaling networks in the skin can guide development of selective pharmacologic intervention of these chronic itch pathways. Bar 5 50 mm. B and C, Representative traces (Fig E2, B) and summarized data (Fig E2, C) show that 0.3 mmol/L GSK101 elicited a [Ca 21 ] i response in freshly isolated TRPV4-eGFP 1 ear skin single-cell suspensions, which was inhibited by 0.3 mmol/L GSK219 or 5 mmol/L HC067. ***P < .001, ANOVA (n 5 11 coverslips for GSK101 and 5 coverslips for GSK219 and HC067). n.s., Not significant. 
